Confirmatory Clinical Trial for Verifying the Efficacy and Safety of 'ALZGUARD' as a Digital Dementia Diagnostic Aid-Tool for the Diagnosis of the Major Neurocognitive Disorders

StatusUnknown
PhaseNot applicable
Started

Record status This record was last updated September 26, 2024 (before its estimated April 30, 2025 completion). Its status may not reflect the trial's current state.

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

  1. Changed Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Recruiting
  2. Study First Submitted
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
HAII corp.ltd
2 trials monitored
See all monitored trials
Dementia
1,982 trials monitored
See 105 trials at risk
The goal of this clinical trial is to evalute the efficacy of ALZGUARD, a smartphone-based digital therapeutic(DTx), in comparison to diagnosis by medical doctors, as weel as to assess the safety of the application.
Trial Details
NCT Number NCT06615167
Lead Sponsor HAII corp.ltd
Conditions
(from sponsor)		 Dementia, Major Neurocognitive Disorder
Related terms Dementia
Enrollment 122 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov